These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30523762)

  • 1. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
    Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
    MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.
    Wolf Pérez AM; Lorenzen N; Vendruscolo M; Sormanni P
    Methods Mol Biol; 2022; 2313():57-113. PubMed ID: 34478132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An accelerated surface-mediated stress assay of antibody instability for developability studies.
    Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
    MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five computational developability guidelines for therapeutic antibody profiling.
    Raybould MIJ; Marks C; Krawczyk K; Taddese B; Nowak J; Lewis AP; Bujotzek A; Shi J; Deane CM
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4025-4030. PubMed ID: 30765520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.
    Khetan R; Curtis R; Deane CM; Hadsund JT; Kar U; Krawczyk K; Kuroda D; Robinson SA; Sormanni P; Tsumoto K; Warwicker J; Martin ACR
    MAbs; 2022; 14(1):2020082. PubMed ID: 35104168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods.
    Makowski EK; Wu L; Gupta P; Tessier PM
    MAbs; 2021; 13(1):1895540. PubMed ID: 34313532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection.
    Lavoisier A; Schlaeppi JM
    MAbs; 2015; 7(1):77-83. PubMed ID: 25514497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, heterogeneity and developability assessment of therapeutic antibodies.
    Xu Y; Wang D; Mason B; Rossomando T; Li N; Liu D; Cheung JK; Xu W; Raghava S; Katiyar A; Nowak C; Xiang T; Dong DD; Sun J; Beck A; Liu H
    MAbs; 2019; 11(2):239-264. PubMed ID: 30543482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developability assessment during the selection of novel therapeutic antibodies.
    Jarasch A; Koll H; Regula JT; Bader M; Papadimitriou A; Kettenberger H
    J Pharm Sci; 2015 Jun; 104(6):1885-1898. PubMed ID: 25821140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
    Bailly M; Mieczkowski C; Juan V; Metwally E; Tomazela D; Baker J; Uchida M; Kofman E; Raoufi F; Motlagh S; Yu Y; Park J; Raghava S; Welsh J; Rauscher M; Raghunathan G; Hsieh M; Chen YL; Nguyen HT; Nguyen N; Cipriano D; Fayadat-Dilman L
    MAbs; 2020; 12(1):1743053. PubMed ID: 32249670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Prediction of Diffusion Interaction Parameter (k
    Tomar DS; Singh SK; Li L; Broulidakis MP; Kumar S
    Pharm Res; 2018 Aug; 35(10):193. PubMed ID: 30128780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and accurate in silico solubility screening of a monoclonal antibody library.
    Sormanni P; Amery L; Ekizoglou S; Vendruscolo M; Popovic B
    Sci Rep; 2017 Aug; 7(1):8200. PubMed ID: 28811609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions.
    Tomar DS; Li L; Broulidakis MP; Luksha NG; Burns CT; Singh SK; Kumar S
    MAbs; 2017 Apr; 9(3):476-489. PubMed ID: 28125318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
    Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y
    MAbs; 2015; 7(3):553-61. PubMed ID: 25790175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity.
    Zhang Y; Wu L; Gupta P; Desai AA; Smith MD; Rabia LA; Ludwig SD; Tessier PM
    Mol Pharm; 2020 Jul; 17(7):2555-2569. PubMed ID: 32453957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developability assessment for monoclonal antibody drug candidates: a case study.
    Garripelli VK; Wu Z; Gupta S
    Pharm Dev Technol; 2021 Jan; 26(1):11-20. PubMed ID: 32986499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
    Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
    Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies.
    Mock M; Jacobitz AW; Langmead CJ; Sudom A; Yoo D; Humphreys SC; Alday M; Alekseychyk L; Angell N; Bi V; Catterall H; Chen CC; Chou HT; Conner KP; Cook KD; Correia AR; Dykstra A; Ghimire-Rijal S; Graham K; Grandsard P; Huh J; Hui JO; Jain M; Jann V; Jia L; Johnstone S; Khanal N; Kolvenbach C; Narhi L; Padaki R; Pelegri-O'Day EM; Qi W; Razinkov V; Rice AJ; Smith R; Spahr C; Stevens J; Sun Y; Thomas VA; van Driesche S; Vernon R; Wagner V; Walker KW; Wei Y; Winters D; Yang M; Campuzano IDG
    MAbs; 2023; 15(1):2256745. PubMed ID: 37698932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holistic in silico developability assessment of novel classes of small proteins using publicly available sequence-based predictors.
    Pais DAM; Mayer JA; Felderer K; Batalha MB; Eichner T; Santos ST; Kumar R; Silva SD; Kaufmann H
    J Comput Aided Mol Des; 2024 Aug; 38(1):30. PubMed ID: 39164492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.